Rigel Pharmaceuticals
RIGL
$1.10
Share price
0.00%
Change (1 day)
-2.65%
Change (1 year)
Categories
Rigel Pharmaceuticals (RIGL) - Net assets
Net assets on the balance sheet as of December 2023 : -$28.65 M
According to Rigel Pharmaceuticals's latest financial reports the company has -$28.65 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Rigel Pharmaceuticals - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $-28.65 M | 110.37% |
| 2022-12-31 | $-13.62 M | -144.83% |
| 2021-12-31 | $30.37 M | -10.73% |
| 2020-12-31 | $34.02 M | -36.77% |
| 2019-12-31 | $53.81 M | -51.02% |
| 2018-12-31 | $0.10 B | 9.17% |
| 2017-12-31 | $0.10 B | 82.9% |
| 2016-12-31 | $55.02 M | -39.78% |
| 2015-12-31 | $91.38 M | -28.75% |
| 2014-12-31 | $0.12 B | -38.42% |
| 2013-12-31 | $0.20 B | -27.96% |
| 2012-12-31 | $0.28 B | 22.42% |
| 2011-12-31 | $0.23 B | 42.15% |
| 2010-12-31 | $0.16 B | 51.21% |
| 2009-12-31 | $0.10 B | 5.47% |
| 2008-12-31 | $0.10 B | 26.75% |
| 2007-12-31 | $82.18 M | -5.79% |
| 2006-12-31 | $87.22 M | -19.67% |
| 2005-12-31 | $0.10 B | 107.62% |
| 2004-12-31 | $52.3 M | 30.84% |
| 2003-12-31 | $39.97 M | 57.12% |
| 2002-12-31 | $25.44 M | -12.09% |
| 2001-12-31 | $28.94 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $6.23 B | -21,856.74% | 🇺🇸 USA |
 AstraZeneca AZN | $37.50 B | -131,020.96% | 🇬🇧 UK |
 Sangamo Therapeutics
SGMO | $82.88 M | -389.37% | 🇺🇸 USA |